NCT00741806View on ClinicalTrials.gov

Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

March 31, 2010

Conditions
Influenza
Interventions
BIOLOGICAL

GHB04L1

single dose intranasal administration of GHB04L1

OTHER

Placebo

SPGN buffer

Trial Locations (1)

1090

Dept of Clinical Pharmacology, Medical University Vienna, Vienna

Sponsors
All Listed Sponsors
collaborator

Medical University of Vienna

OTHER

lead

AVIR Green Hills Biotechnology AG

INDUSTRY

NCT00741806 - Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults | Biotech Hunter | Biotech Hunter